Skip to main content
. 2018 May 19;73:e203. doi: 10.6061/clinics/2018/e203

Table 2.

Biochemical data according to the extent of the coronary lesion.

Variable Total (74) No lesion (23) Minor lesion (22) Intermediate lesion (20) Major lesion (9) p-value
Glucose, mmol/L 6.17±2.95 5.76±2.34 5.68±1.82 7.10±4.37 6.38±2.62 0.408
Total cholesterol, mmol/L 4.73±1.20 4.47±1.04 4.58±1.02 5+11±1.44 4.91±1.42 0.305
HDL cholesterol, mmol/L 0.98±0.27 1.04±0.31 0.93±0.22 0.93±0.26 1.03±0.29 0.414
LDL cholesterol, mmol/L 2.86±1.07 2.64±0.90 2.68±0.89 3.16±1.31 3.22±1.28 0.261
Triglycerides, mmol/L 1.97±1.48 1.70±1.30 2.11±1.44 2.37±1.87 1.46±0.76 0.157
ALT, µKat/L 0.51±0.36 0.50±0.39 0.52±0.23 0.48±0.45 0.58±0.39 0.298
AST, µKat/L 0.57±0.32 0.65±0.38 0.54±0.29 0.51±0.22 0.63±0.39 0.639
Urea, mmol/L 13.45±3.72 13.03±3.68 13.52±3.26 14.10±4.40 12.98±3.82 0.864
Creatinine K, µmol/L 84.0±258 85.0±24.2 81.6±20.0 89.7±28.3 74.6±36.7 0.505
Uric acid, mmol/L 0.29±0.09 0.29±0.10 0.30±0.10 0.28±0.10 0.28±0.08 0.965
E-selectin, ng/mL 32.5±16.8 33.5±19.8 30.4±14.6 34.4±17.3 30.6±14.6 0.855
VCAM-1, ng/mL 990.0±270.3 994.3±330.3 899.7±214.7 1080.2±282.0 998.9±118.3 0.196
ICAM-1, ng/mL 152.2±53.7 152.6±68.4 161.9±58.0 144.9±39.5 144.0±21.1 0.695
MMP9, ng/mL 324.2±156.4 348.8±198.5 302.9±127.7 351.8±146.3 252.2±102.6 0.325

Number of individuals in parentheses. Continuous variables are presented as the mean ± standard deviation and compared using the Kruskal–Wallis test or ANOVA. Categorical variables were compared using the Chi-square test. HDL: high-density lipoprotein; LDL: low-density lipoprotein; AST: alanine aminotransferase; and ALT: aspartate aminotransferase. p-values <0.05 were considered statistically significant.